Sung H, Ferlay J, Siegel RL, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. Ca Cancer J Clin. 2021;71(3):209–49.

PubMed  Google Scholar 

Sharma R, Abbasi-Kangevari M, Abd-Rabu R, Abidi H, Abu-Gharbieh E, Acuna JM, Adhikari S, Advani SM, Afzal MS, Meybodi MA, Ahinkorah B. Global, regional, and national burden of colorectal cancer and its risk factors, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet Gastroenterol Hepatol. 2022;7(7):627–47.

CAS  Google Scholar 

Benson AB, Venook AP, Al-Hawary MM, et al. Colon Cancer, Version 2.2021, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2021;19(3):329–59.

PubMed  Google Scholar 

Chen L, Wang C, Sun H, et al. The bioinformatics toolbox for circRNA discovery and analysis. Brief Bioinform. 2021;22(2):1706–28.

CAS  PubMed  Google Scholar 

Zhou WY, Cai ZR, Liu J, et al. Circular RNA: metabolism, functions and interactions with proteins. Mol Cancer. 2020;19(1):172.

CAS  PubMed  PubMed Central  Google Scholar 

Chen LL. The expanding regulatory mechanisms and cellular functions of circular RNAs. Nat Rev Mol Cell Biol. 2020;21(8):475–90.

CAS  PubMed  Google Scholar 

Li S, Wang J, Ren G. CircRNA: an emerging star in plant research: a review. Int J Biol Macromol. 2024;272(Pt 2): 132800.

CAS  PubMed  Google Scholar 

Misir S, Wu N, Yang BB. Specific expression and functions of circular RNAs. Cell Death Differ. 2022;29(3):481–91.

CAS  PubMed  PubMed Central  Google Scholar 

Long F, Lin Z, Li L, et al. Comprehensive landscape and future perspectives of circular RNAs in colorectal cancer. Mol Cancer. 2021;20(1):26.

CAS  PubMed  PubMed Central  Google Scholar 

Huang A, Zheng H, Wu Z, et al. Circular RNA-protein interactions: functions, mechanisms, and identification. Theranostics. 2020;10(8):3503–17.

CAS  PubMed  PubMed Central  Google Scholar 

Yang B, Wang YW, Zhang K. Interactions between circRNA and protein in breast cancer. Gene. 2024;895: 148019.

CAS  PubMed  Google Scholar 

Bell JL, Wachter K, Muhleck B, et al. Insulin-like growth factor 2 mRNA-binding proteins (IGF2BPs): post-transcriptional drivers of cancer progression? Cell Mol Life Sci. 2013;70(15):2657–75.

CAS  PubMed  Google Scholar 

Wang Y, Lu JH, Wu QN, et al. LncRNA LINRIS stabilizes IGF2BP2 and promotes the aerobic glycolysis in colorectal cancer. Mol Cancer. 2019;18(1):174.

CAS  PubMed  PubMed Central  Google Scholar 

Cao J, Mu Q, Huang H, et al. The roles of insulin-like growth factor 2 mRNA-binding protein 2 in cancer and cancer stem cells. Stem Cells Int. 2018;2018:4217215–59.

Google Scholar 

Pan X, Huang B, Ma Q, et al. Circular RNA circ-TNPO3 inhibits clear cell renal cell carcinoma metastasis by binding to IGF2BP2 and destabilizing SERPINH1 mRNA[J]. Clin Transl Med. 2022;12(7): e994.

CAS  PubMed  PubMed Central  Google Scholar 

Huang C, Xu R, Zhu X, et al. m6A-modified circABCC4 promotes stemness and metastasis of prostate cancer by recruiting IGF2BP2 to increase stability of CCAR1[J]. Cancer Gene Ther. 2023;30(10):1426–40.

CAS  PubMed  Google Scholar 

Zhong S, Wang J, Zhang Q, et al. CircPrimer: a software for annotating circRNAs and determining the specificity of circRNA primers[J]. BMC Bioinform. 2018;19(1):292.

Google Scholar 

Kasprzak A, Adamek A. Insulin-Like Growth Factor 2 (IGF2) signaling in colorectal cancer-from basic research to potential clinical applications. Int J Mol Sci. 2019;20(19):4915.

CAS  PubMed  PubMed Central  Google Scholar 

Hao Q, Zhang M, Wu Y, et al. Hsa_circRNA_001676 accelerates the proliferation, migration and stemness in colorectal cancer through regulating miR-556-3p/G3BP2 axis. Sci Rep. 2023;13(1):18353.

CAS  PubMed  PubMed Central  Google Scholar 

Long F, Li L, Xie C, et al. Intergenic CircRNA Circ_0007379 inhibits colorectal cancer progression by modulating miR-320a biogenesis in a KSRP-dependent manner. Int J Biol Sci. 2023;19(12):3781–803.

CAS  PubMed  PubMed Central  Google Scholar 

Lin J, Lian X, Xue S, et al. HBV promotes the proliferation of liver cancer cells through the hsa_circ_0000847/miR-135a pathway. Evid Based Compl Alternat Med. 2022;2022:7332337.

Google Scholar 

Zhang W, Wu G, Sun P, et al. circ_SMAD2 regulate colorectal cancer cells proliferation through targeting miR-1258/RPN2 signaling pathway[J]. J Cancer. 2021;12(6):1678–86.

CAS  PubMed  PubMed Central  Google Scholar 

Jeck WR, Sharpless NE. Detecting and characterizing circular RNAs[J]. Nat Biotechnol. 2014;32(5):453–61.

CAS  PubMed  PubMed Central  Google Scholar 

Zhang YE, Stuelten CH. Alternative splicing in EMT and TGF-beta signaling during cancer progression[J]. Semin Cancer Biol. 2024;101:1–11.

CAS  PubMed  PubMed Central  Google Scholar 

Ang HL, Mohan CD, Shanmugam MK, et al. Mechanism of epithelial-mesenchymal transition in cancer and its regulation by natural compounds[J]. Med Res Rev. 2023;43(4):1141–200.

CAS  PubMed  Google Scholar 

Zang J, Lu D, Xu A. The interaction of circRNAs and RNA binding proteins: an important part of circRNA maintenance and function. J Neurosci Res. 2020;98(1):87–97.

CAS  PubMed  Google Scholar 

Jiang X, Guo S, Wang S, et al. EIF4A3-Induced circARHGAP29 promotes aerobic glycolysis in docetaxel-resistant prostate cancer through IGF2BP2/c-Myc/LDHA signaling. Cancer Res. 2022;82(5):831–45.

CAS  PubMed  Google Scholar 

Yao B, Zhang Q, Yang Z, et al. CircEZH2/miR-133b/IGF2BP2 aggravates colorectal cancer progression via enhancing the stability of m(6)A-modified CREB1 mRNA[J]. Mol Cancer. 2022;21(1):140.

CAS  PubMed  PubMed Central  Google Scholar 

Burns JL, Hassan AB. Cell survival and proliferation are modified by insulin-like growth factor 2 between days 9 and 10 of mouse gestation[J]. Development (Cambridge). 2001;128(19):3819–30.

CAS  Google Scholar 

Baker J, Liu J, Robertson EJ, et al. Role of insulin-like growth factors in embryonic and postnatal growth[J]. Cell. 1993;75(1):73–82.

CAS  PubMed  Google Scholar 

Livingstone C. IGF2 and cancer. Endocr Relat Cancer. 2013;20(6):R321–39.

CAS  PubMed  Google Scholar 

Unger C, Kramer N, Unterleuthner D, et al. Stromal-derived IGF2 promotes colon cancer progression via paracrine and autocrine mechanisms. Oncogene. 2017;36(38):5341–55.

CAS  PubMed  Google Scholar 

Afshar S, Najafi R, Sedighi PA, et al. MiR-185 enhances radiosensitivity of colorectal cancer cells by targeting IGF1R and IGF2. Biomed Pharmacother. 2018;106:763–9.

CAS  PubMed  Google Scholar 

Rogers MA, Kalter V, Strowitzki M, et al. IGF2 knockdown in two colorectal cancer cell lines decreases survival, adhesion and modulates survival-associated genes. Tumour Biol. 2016;37(9):12485–95.

CAS  PubMed  Google Scholar 

Ewing GP, Goff LW. The insulin-like growth factor signaling pathway as a target for treatment of colorectal carcinoma. Clin Colorectal Cancer. 2010;9(4):219–23.

PubMed  Google Scholar